CHERILOU CONCEPCION: Open Payments
NPI 1679191951 · ONTARIO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 17 payments from 6 companies in 2025. Trend: 2023 $901 · 2024 $415 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $161 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Galderma Laboratories, L.P. | 1 | $22 |
| LNHC, Inc | 1 | $15 |
| GENZYME CORPORATION | 1 | $15 |
Products named: Bimzelx, DUPIXENT, Rhapsido, DYSPORT, COSENTYX, ZELSUVMI.
Industry payments across CA — which companies pay providers there.
